These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 23017810)
1. Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone. Künzel HE; Apostolopoulou K; Pallauf A; Gerum S; Merkle K; Schulz S; Fischer E; Brand V; Bidlingmaier M; Endres S; Beuschlein F; Reincke M J Psychiatr Res; 2012 Dec; 46(12):1650-4. PubMed ID: 23017810 [TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. Ahmed AH; Gordon RD; Sukor N; Pimenta E; Stowasser M J Clin Endocrinol Metab; 2011 Sep; 96(9):2904-11. PubMed ID: 21778218 [TBL] [Abstract][Full Text] [Related]
3. Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study. Köhler A; Sarkis AL; Heinrich DA; Müller L; Handgriff L; Deniz S; Schneider H; Künzel H; Ladurner R; Reincke M; Adolf C Eur J Endocrinol; 2021 Oct; 185(5):663-672. PubMed ID: 34468397 [TBL] [Abstract][Full Text] [Related]
4. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. Sukor N; Kogovsek C; Gordon RD; Robson D; Stowasser M J Clin Endocrinol Metab; 2010 Mar; 95(3):1360-4. PubMed ID: 20089615 [TBL] [Abstract][Full Text] [Related]
5. Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study. Apostolopoulou K; Künzel HE; Gerum S; Merkle K; Schulz S; Fischer E; Pallauf A; Brand V; Bidlingmaier M; Endres S; Beuschlein F; Reincke M World J Biol Psychiatry; 2014 Jan; 15(1):26-35. PubMed ID: 22568586 [TBL] [Abstract][Full Text] [Related]
6. Worsening of lipid metabolism after successful treatment of primary aldosteronism. Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655 [TBL] [Abstract][Full Text] [Related]
7. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism. Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564 [TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M; J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370 [TBL] [Abstract][Full Text] [Related]
9. Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment. Velema M; Dekkers T; Hermus A; Timmers H; Lenders J; Groenewoud H; Schultze Kool L; Langenhuijsen J; Prejbisz A; van der Wilt GJ; Deinum J; J Clin Endocrinol Metab; 2018 Jan; 103(1):16-24. PubMed ID: 29099925 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. Fischer E; Beuschlein F; Degenhart C; Jung P; Bidlingmaier M; Reincke M Clin Endocrinol (Oxf); 2012 Apr; 76(4):473-7. PubMed ID: 21958049 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety. Murck H; Adolf C; Schneider A; Schlageter L; Heinrich D; Ritzel K; Sturm L; Quinkler M; Beuschlein F; Reincke M; Künzel H J Psychiatr Res; 2021 May; 137():376-382. PubMed ID: 33761426 [TBL] [Abstract][Full Text] [Related]
12. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry. Parra Ramírez P; Martín Rojas-Marcos P; Paja Fano M; González-Boillos M; Pascual-Corrales E; García Cano AM; Ruiz-Sanchez JG; Vicente Delgado A; Gómez Hoyos E; Ferreira R; García Sanz I; Recasens Sala M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; Rebollo Román Á; Robles Lázaro C; Morales-Ruiz M; Calatayud M; Andree Furio Collao S; Meneses D; Sampedro-Nuñez MA; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano Gotarredona J; Michalopoulou Alevras T; Tenés Rodrigo S; Roa Chamorro R; Jaen Aguila F; Moya Mateo EM; Hanzu FA; Araujo-Castro M High Blood Press Cardiovasc Prev; 2024 Jan; 31(1):43-53. PubMed ID: 38225508 [TBL] [Abstract][Full Text] [Related]
13. Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry. Fischer E; Reuschl S; Quinkler M; Rump LC; Hahner S; Bidlingmaier M; Reincke M; Horm Metab Res; 2013 Jul; 45(7):526-31. PubMed ID: 23613013 [TBL] [Abstract][Full Text] [Related]
14. Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism. Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chung SD; Endocrinol Metab (Seoul); 2020 Dec; 35(4):838-846. PubMed ID: 33261310 [TBL] [Abstract][Full Text] [Related]
15. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911 [TBL] [Abstract][Full Text] [Related]
16. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry. Grotevendt A; Wallaschofski H; Reincke M; Adolf C; Quinkler M; Nauck M; Hoffmann W; Rettig R; Hannemann A Endocrine; 2017 Aug; 57(2):298-307. PubMed ID: 28638984 [TBL] [Abstract][Full Text] [Related]
17. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness. Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease. Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014 [TBL] [Abstract][Full Text] [Related]
19. [Metabolic Outcomes of Primary Aldosteronism Patients Receiving Adrenalectomy or Spironolactone Treatments]. Xu C; Chen T; Mo D; Zhang T; Zhou F; Tian H; Ren Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1227-1232. PubMed ID: 38162054 [TBL] [Abstract][Full Text] [Related]
20. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Riester A; Reincke M Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]